stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Current ratio
Intuitive Surgical, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.3×, down 1.5× from fiscal 2025 (4.9×). Over the past ten years it has ranged from 4.1× (fiscal 2024) to 6.9× (fiscal 2020); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 4.9× | 19.64% |
| FY2024 | 4.1× | (14.32%) |
| FY2023 | 4.8× | 8.15% |
| FY2022 | 4.4× | (13.50%) |
| FY2021 | 5.1× | (25.95%) |
| FY2020 | 6.9× | 51.68% |
| FY2019 | 4.5× | (14.29%) |
| FY2018 | 5.3× | 24.60% |
| FY2017 | 4.2× | (22.23%) |
| FY2016 | 5.4× | 22.09% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 3.3× | (32.95%) |
| Jun 2026 | 5.0× | 7.65% |
| Mar 2026 | 4.6× | (5.43%) |
| Dec 2025 | 4.9× | 3.10% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| MDLN Medline Inc. compare | 4.0× |
| ISRG Intuitive Surgical, Inc. | 3.3× |
| WST West Pharmaceutical Services, Inc. compare | 2.8× |
| RMD ResMed Inc. compare | 2.6× |
| ALC Alcon compare | 2.1× |
| BAX Baxter International Inc. compare | 1.8× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| SOLV Solventum Corporation compare | 1.0× |
| BDX Becton, Dickinson and Company compare | 0.9× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement